7-Amino-4-hydroxy-2-naphthalenesulfonic acid was mutagenic to Salmonella typhimurium, TA100, TA98, TA1535 and TA1537 with an exogeneous metabolic activation system.
7-Amino-4-hydroxy-2-naphthalenesulfonic acid induced neither structural chromosomal aberrations nor polyploidy in CHL/IU cells, in the absence or presence of an exogenous metabolic activation system.
Purity | : | 91.8% |
Test species/strain | : | Rat/Crj:CD (SD) |
Test method | : | Guidelines for 28-day Repeat Dose Toxicity Testing of Chemicals (Japan) |
Route | : | Oral (gavage) |
Doses | : | 0 (vehicle), 250, 500, 1000 mg/kg/day |
Number of animals/group | : | Males, 6 and 12 (0, 1000 mg/kg) Females, 6 and 12 (0, 1000 mg/kg) |
Vehicle | : | 5% gum arabic solution |
Administration period | : | Males and females, 28 days |
Terminal kill | : | Days 29 or 43 |
GLP | : | Yes |
Test results:
Purity | : | 91.8% |
Test species/strains | : | S. typhimurium TA100, TA1535, TA98, TA1537, E. coli WP2 uvrA |
Test method | : | Guidelines for Screening Mutagenicity Testing of Chemicals (Japan) |
Procedures | : | Pre-incubation method |
Solvent | : | DMSO |
Positive controls | : | -S9 mix;AF-2 (TA100, TA98 and WP2 uvrA), Sodium azide (TA1535), 9-Aminoacridine (TA1537) +S9 mix;2-Aminoanthracene (all strains) |
Doses | : | 156, 313, 625, 1250, 2500, 5000 μg/plate |
S9 | : | Rat liver, induced with phenobarbital and 5,6-benzoflavone |
Plates/test | : | 3 |
Number of replicates | : | 2 |
GLP | : | Yes |
Genetic effects:
S. typhimurium TA100, TA1535, TA98 and TA1537
+ | ? | - | |
Without metabolic activation: | [ ] | [ ] | [*] |
With metabolic activation: | [*] | [ ] | [ ] |
E. coli WP2 uvrA
+ | ? | - | |
Without metabolic activation: | [ ] | [ ] | [*] |
With metabolic activation: | [ ] | [*] | [ ] |
Purity | : | 91.8% |
Type of cell used | : | Chinese hamster lung (CHL) cells |
Test method | : | Guidelines for Screening Mutagenicity Testing of Chemicals (Japan) |
Solvent | : | DMSO |
Positive controls | : | long-term treatment; Mitomycin C (24 h and 48 h) short-term treatment; Cyclophosphamide (+S9 and -S9 mix) |
Doses | : | long-term treatment; 0, 375, 750, 1500 μg/ml (24 h and 48 h) short-term treatment; 0, 375, 750, 1500 μg/ml (+S9 and -S9 mix) |
S9 | : | Rat liver, induced with phenobarbital and 5,6-benzoflavone |
Plates/test | : | 2 |
GLP | : | Yes |
clastogenicity | polyploidy | |||||
+ | ? | - | + | ? | - | |
Without metabolic activation: | [ ] | [ ] | [*] | [ ] | [ ] | [*] |
With metabolic activation: | [ ] | [ ] | [*] | [ ] | [ ] | [*] |
1) | The tests were performed by Safety Assessment Laboratory, Panapharm Laboratories Co., Ltd. 1285 Kurisaki-machi, Uto-shi, Kumamoto, 869-04, Japan. Tel +81-964-23-5111 Fax +81-964-23-2282 |
2) | The tests were performed by the Biosafety Research Center, Foods, Drugs and Pesticides (An-pyo Center), Japan, 582-2 Shioshinden Arahama, Fukude-cho, Iwata-gun, Shizuoka, 437-12, Japan. Tel +81-538-58-1266 Fax +81-538-58-1393 |